Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

The effect of Rho-associated kinase inhibition on the ocular penetration of timolol maleate.

Arnold JJ, Hansen MS, Gorman GS, Inoue T, Rao V, Spellen S, Hunsinger RN, Chapleau CA, Pozzo-Miller L, Stamer WD, Challa P.

Invest Ophthalmol Vis Sci. 2013 Feb 7;54(2):1118-26. doi: 10.1167/iovs.12-10583.

2.

The transcorneal penetration of commercial ophthalmic formulations containing timolol maleate in rabbit eyes.

Fukuda M, Sasaki H.

J Ocul Pharmacol Ther. 2015 Feb;31(1):57-60. doi: 10.1089/jop.2014.0015.

PMID:
25303115
3.

Improved ocular: systemic absorption ratio of timolol by viscous vehicle and phenylephrine.

Kyyrönen K, Urtti A.

Invest Ophthalmol Vis Sci. 1990 Sep;31(9):1827-33.

PMID:
2211028
4.

Pharmacokinetic basis for nonadditivity of intraocular pressure lowering in timolol combinations.

Lee VH, Luo AM, Li SY, Podder SK, Chang JS, Ohdo S, Grass GM.

Invest Ophthalmol Vis Sci. 1991 Oct;32(11):2948-57.

PMID:
1917398
5.

AMA0076, a novel, locally acting Rho kinase inhibitor, potently lowers intraocular pressure in New Zealand white rabbits with minimal hyperemia.

Van de Velde S, Van Bergen T, Sijnave D, Hollanders K, Castermans K, Defert O, Leysen D, Vandewalle E, Moons L, Stalmans I.

Invest Ophthalmol Vis Sci. 2014 Feb 18;55(2):1006-16. doi: 10.1167/iovs.13-13157.

PMID:
24474276
7.

Xyloglucan as a novel vehicle for timolol: pharmacokinetics and pressure lowering activity in rabbits.

Burgalassi S, Chetoni P, Panichi L, Boldrini E, Saettone MF.

J Ocul Pharmacol Ther. 2000 Dec;16(6):497-509.

PMID:
11132897
8.

Ocular Penetration and Pharmacokinetics of Ripasudil Following Topical Administration to Rabbits.

Isobe T, Kasai T, Kawai H.

J Ocul Pharmacol Ther. 2016 Sep;32(7):405-14. doi: 10.1089/jop.2016.0028. Epub 2016 Jul 27.

PMID:
27463221
9.

Physicochemical and pharmacological investigation of water/oil microemulsion of non-selective beta blocker for treatment of glaucoma.

Hegde RR, Bhattacharya SS, Verma A, Ghosh A.

Curr Eye Res. 2014 Feb;39(2):155-63. doi: 10.3109/02713683.2013.833630. Epub 2013 Sep 27.

PMID:
24073659
10.

Improved ocular absorption kinetics of timolol maleate loaded into a bioadhesive niosomal delivery system.

Kaur IP, Aggarwal D, Singh H, Kakkar S.

Graefes Arch Clin Exp Ophthalmol. 2010 Oct;248(10):1467-72. doi: 10.1007/s00417-010-1383-0. Epub 2010 May 2.

PMID:
20437246
11.

Pharmacokinetics and intraocular pressure lowering effect of timolol preparations in rabbit eyes.

Chiang CH, Ho JI, Chen JL.

J Ocul Pharmacol Ther. 1996 Winter;12(4):471-80.

PMID:
8951683
12.

Improving the ocular to systemic ratio of topical timolol by varying the dosing time.

Ohdo S, Grass GM, Lee VH.

Invest Ophthalmol Vis Sci. 1991 Sep;32(10):2790-8.

PMID:
1894477
13.

Application site dependent ocular absorption of timolol.

Urtti A, Sendo T, Pipkin JD, Rork G, Repta AJ.

J Ocul Pharmacol. 1988 Winter;4(4):335-43.

PMID:
3246568
14.

Improvement of the ocular bioavailability of timolol by sorbic acid.

Higashiyama M, Inada K, Ohtori A, Tojo K.

Int J Pharm. 2004 Mar 19;272(1-2):91-8.

PMID:
15019072
15.

Corneal penetration behavior of beta-blocking agents III: In vitro-in vivo correlations.

Huang HS, Schoenwald RD, Lach JL.

J Pharm Sci. 1983 Nov;72(11):1279-81.

PMID:
6139473
16.
17.

Effects of L-NAME and timolol on aqueous IL-1beta, IL-6, IL-8, TNF-alpha and NO levels after Nd:YAG laser iridotomy in rabbits.

Er H, Doganay S, Evereklioglu C, Cekmen M, Daglioglu MC, Isci N.

Eur J Ophthalmol. 2002 Jul-Aug;12(4):281-6.

PMID:
12219997
18.

Evaluation of aqueous humor concentrations of Istalol and Betimol following a single ocular instillation in rabbit eyes.

Baklayan GA, Collins EC, Thetford T, Soriano A, Song CK, Han J.

J Ocul Pharmacol Ther. 2008 Oct;24(5):507-12. doi: 10.1089/jop.2007.0131.

PMID:
18800867
19.

Pharmacokinetics of topical beta-adrenergic antagonists in rabbit aqueous humor evaluated with the microdialysis method.

Ohtori R, Sato H, Fukuda S, Ueda T, Koide R, Kanda Y, Kiuchi Y, Oguchi K.

Exp Eye Res. 1998 Apr;66(4):487-94.

PMID:
9593641
20.

Ocular pharmacokinetics of dorzolamide and brinzolamide after single and multiple topical dosing: implications for effects on ocular blood flow.

Kadam RS, Jadhav G, Ogidigben M, Kompella UB.

Drug Metab Dispos. 2011 Sep;39(9):1529-37. doi: 10.1124/dmd.111.040055. Epub 2011 Jun 14.

Supplemental Content

Support Center